Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmaceutical Science,Pharmacology,Toxicology,Pharmacy
Reference27 articles.
1. World Health Organization. The Importance of Pharmacovigilance: safety monitoring of medicinal products (2002). http://apps.who.int/medicinedocs/en/d/Js4893e/. Assessed 19 Dec 2017.
2. Pal SN, Duncombe C, Falzon D, Olsson S. WHO strategy for collecting safety data in public health programmes: complementing spontaneous reporting systems. Drug Saf. 2013;36:75–81.
3. van Grootheest K, de Graaf L, de Jong-van den Berg LTW. Consumer adverse drug reaction reporting: a new step in pharmacovigilance? Drug Saf. 2003;26:211–7.
4. Banovac M, Candore G, Slattery J, Houÿez F, Haerry D, Genov G, et al. Patient reporting in the EU: analysis of eudravigilance data. Drug Saf. 2017;40:629–45.
5. Borg J-J, Aislaitner G, Pirozynski M, Mifsud S. Strengthening and rationalizing pharmacovigilance in the EU: where is Europe heading to? Drug Saf. 2011;34:187–97.
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献